SR
Shilpa Rastogi
About Shilpa Rastogi
Data last updated:
Shilpa Rastogi has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Craza Lifesciences Private Limited and Genzen Lifesciences Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Craza Lifesciences Private Limited at ₹1.29 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Nov 2016 | 2016 | ₹1.29 Cr (FY 2024) | Active | |
| Designated Partner | 26 Apr 2023 | 2017 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shilpa Rastogi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shilpa Rastogi
Shilpa Rastogi has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Craza Lifesciences Private Limited and Genzen Lifesciences Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Craza Lifesciences Private Limited at ₹1.29 Cr (FY 2024).
Shilpa Rastogi is associated with 2 companies as Director and Designated Partner, including Craza Lifesciences Private Limited (₹1.29 Cr), Genzen Lifesciences Llp.
Shilpa Rastogi has expertise in General Business.
Shilpa Rastogi has 9 years in corporate governance.
By reported revenue, the largest current company of Shilpa Rastogi is Craza Lifesciences Private Limited, with revenue of ₹1.29 Cr (FY 2024).
Shilpa Rastogi currently holds positions at 2 companies: Craza Lifesciences Private Limited (₹1.29 Cr), Genzen Lifesciences Llp.